The core concept
Red-light and near-infrared devices use specific bands of non-ionizing light. In photobiomodulation research, wavelength, dose, tissue target and protocol all matter. consumer marketing often compresses those variables into a few headline specifications.
What to compare
When reading a product specification sheet, note the wavelength distribution, irradiance measurement conditions, treatment distance guidance, exposure-time guidance, panel dimensions and control options. None should be interpreted in isolation.
Keep evidence tied to the use
Evidence for one wavelength, protocol or clinical context should not automatically be generalized to every home device or health claim. Our health-related pages use conservative language for that reason.
Why panels use more than one wavelength
Consumer panels often combine visible red light with near infrared light. The mix lets a manufacturer cover more than one wavelength band in the same session. That can be convenient, but the number of wavelengths is not a quality score.
What 660 nm and 850 nm actually mean
The number is the wavelength of the light in nanometers. A label such as 660 nm tells you where that LED sits in the spectrum. It does not tell you the dose reaching your skin, how evenly the panel distributes light, or whether a particular health outcome has been demonstrated for that device.
Why exact numbers should not become magic numbers
Research uses ranges of red and near infrared wavelengths. Results also depend on dose, tissue, treatment schedule, and study design. Two panels can list the same wavelength and still deliver a different exposure in practice.
Sources used for this guide
Our evidence review includes guidance from the American Academy of Dermatology, FDA material on photobiomodulation and light based procedures, and peer reviewed photobiomodulation reviews indexed by the National Library of Medicine. Sources are checked for relevance to the specific claim rather than treated as endorsements of a consumer product.